United States Biotechnology & Medical Research

Novelion Therapeutics Inc (NVLNF)

Track

Ticker: NVLNF Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 12 Dec 2019
Value US$2,716,053.47 | Price 426.36 | Shares 38,424 (-11.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-12 2019-12-12 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
38,424 -11.1%
426.36
US$2,716,053 		38,424 -11.1% 426.36 US$2,716,053
2019-12-12 2019-12-11 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
62,142 +40.0%
50.33
US$100,488 		62,142 +40.0% 50.33 US$100,488
2019-12-12 2019-12-10 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
90,213 +23.3%
193.69
US$4,937,356 		90,213 +23.3% 193.69 US$4,937,356
2019-12-09 2019-12-09 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
4,500 +0.1%
0.70
US$3,150 		4,500 +0.1% 0.70 US$3,150
2019-12-09 2019-12-06 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
40 +0.0%
0.70
US$28 		40 +0.0% 0.70 US$28
2019-12-09 2019-12-05 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
5,160 +0.1%
0.70
US$3,612 		5,160 +0.1% 0.70 US$3,612
2019-11-26 2019-11-22 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
89,845 +2.4%
0.75
US$67,033 		89,845 +2.4% 0.75 US$67,033
2019-10-16 2019-10-11 B Purchase
STONEPINE CAPITAL, L.P.
Large shareholder
100,000 +2.7%
0.65
US$64,900 		100,000 +2.7% 0.65 US$64,900
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -6.3%
0.85
US$85,140 		100,000 -6.3% 0.85 US$85,140
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
56,316 -3.4%
0.85
US$48,139 		56,316 -3.4% 0.85 US$48,139
2018-12-27 2018-12-27 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
14,800 -0.9%
0.88
US$13,028 		14,800 -0.9% 0.88 US$13,028
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
30,726 -1.8%
0.91
US$27,868 		30,726 -1.8% 0.91 US$27,868
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
28,745 -1.7%
0.91
US$26,037 		28,745 -1.7% 0.91 US$26,037
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
12,219 -0.7%
0.91
US$11,108 		12,219 -0.7% 0.91 US$11,108
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
109,900 -5.9%
0.87
US$95,833 		109,900 -5.9% 0.87 US$95,833
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
12,450 -0.7%
0.91
US$11,302 		12,450 -0.7% 0.91 US$11,302
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
83,245 -4.3%
0.98
US$81,447 		83,245 -4.3% 0.98 US$81,447
2018-12-27 2018-12-26 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,200 -0.1%
0.93
US$1,119 		1,200 -0.1% 0.93 US$1,119
2018-12-27 2018-12-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
400 -0.0%
0.98
US$392 		400 -0.0% 0.98 US$392
2017-06-13 2017-06-12 B Purchase Stern Donald K
2,500 +inf%
9.10
US$22,750 		2,500 +inf% 9.10 US$22,750
2017-05-17 2017-05-15 B Purchase Aryeh Jason Non-Executive Director
361 +0.1%
8.95
US$3,231 		361 +0.1% 8.95 US$3,231
2016-09-15 2016-09-15 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
14,928 +0.3%
1.55
US$23,138 		14,928 +0.3% 1.55 US$23,138
2016-09-15 2016-09-14 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
56,864 +1.0%
1.55
US$88,270 		56,864 +1.0% 1.55 US$88,270
2016-09-15 2016-09-13 B Purchase STONEPINE CAPITAL, L.P. Large shareholder
61,704 +1.1%
1.54
US$95,166 		61,704 +1.1% 1.54 US$95,166
2015-12-30 2015-12-29 B Purchase Aryeh Jason Non-Executive Director
400 +0.1%
2.49
US$996 		400 +0.1% 2.49 US$996
2015-12-30 2015-12-29 B Purchase Aryeh Jason Non-Executive Director
18,000 +4.1%
2.50
US$45,000 		18,000 +4.1% 2.50 US$45,000
2015-06-18 2015-06-16 B Purchase Aryeh Jason Non-Executive Director
288,000 +inf%
3.47
US$999,360 		288,000 +inf% 3.47 US$999,360
2015-06-17 2015-06-16 S Sale AXIAL CAPITAL MANAGEMENT, LLC Large shareholder
8,865,036 -100.0%
3.47
US$30,771,426 		8,865,036 -100.0% 3.47 US$30,771,426
2015-06-17 2015-06-16 S Sale Axial Capital Master, L.P. Large shareholder
7,563,053 -100.0%
3.47
US$26,252,113 		7,563,053 -100.0% 3.47 US$26,252,113
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +4.3%
3.62
US$3,258 		900 +4.3% 3.62 US$3,258
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
600 +2.9%
3.62
US$2,172 		600 +2.9% 3.62 US$2,172
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
4,400 +27.3%
3.62
US$15,928 		4,400 +27.3% 3.62 US$15,928
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +5.9%
3.62
US$3,258 		900 +5.9% 3.62 US$3,258
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
600 +4.1%
3.63
US$2,178 		600 +4.1% 3.63 US$2,178
2014-12-23 2014-12-22 B Purchase KOZARICH JOHN W Non-Executive Director
900 +6.6%
3.63
US$3,267 		900 +6.6% 3.63 US$3,267
2014-12-23 2014-12-19 B Purchase KOZARICH JOHN W Non-Executive Director
1,700 +14.2%
3.45
US$5,865 		1,700 +14.2% 3.45 US$5,865
2014-12-19 2014-12-18 B Purchase Meckler Jeffrey A Non-Executive Director
20,000 +38.5%
3.60
US$72,000 		20,000 +38.5% 3.60 US$72,000
2014-07-15 2014-07-11 S Sale NB Public Equity K/S Large shareholder
1,000,000 -13.4%
5.80
US$5,800,000 		1,000,000 -13.4% 5.80 US$5,800,000
2013-07-02 2013-07-01 S Sale Axial Capital Master, L.P. Large shareholder
288,890 -3.7%
4.39
US$1,268,227 		288,890 -3.7% 4.39 US$1,268,227
2013-07-01 2013-06-28 B Purchase Meckler Jeffrey A Non-Executive Director
30,000 +150.0%
4.36
US$130,800 		30,000 +150.0% 4.36 US$130,800
2013-05-15 2013-05-14 S Sale Jagpal Sukhi

Chief Financial Officer

Officer
100 -7.7%
7.96
US$796 		100 -7.7% 7.96 US$796
2013-05-15 2013-05-14 S Sale Jagpal Sukhi

Chief Financial Officer

Officer
9,900 -88.4%
7.95
US$78,705 		9,900 -88.4% 7.95 US$78,705
2013-05-14 2013-05-13 B Purchase KOZARICH JOHN W Non-Executive Director
10,000 +inf%
7.97
US$79,700 		10,000 +inf% 7.97 US$79,700
2013-05-06 2013-05-03 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
90,000 -81.8%
7.85
US$706,500 		90,000 -81.8% 7.85 US$706,500
2013-05-06 2013-05-03 B Purchase Meckler Jeffrey A Non-Executive Director
20,000 +inf%
7.96
US$159,200 		20,000 +inf% 7.96 US$159,200
2012-12-28 2012-12-28 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
50,000 -71.4%
7.51
US$375,315 		50,000 -71.4% 7.51 US$375,315
2012-12-28 2012-12-27 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
180,000 -90.0%
7.53
US$1,354,734 		180,000 -90.0% 7.53 US$1,354,734
2012-12-13 2012-12-12 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
8.02
US$40,100 		5,000 -20.0% 8.02 US$40,100
2012-11-29 2012-11-28 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.88
US$39,400 		5,000 -20.0% 7.88 US$39,400
2012-11-21 2012-11-20 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.81
US$39,050 		5,000 -20.0% 7.81 US$39,050
2012-11-05 2012-11-01 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.52
US$37,600 		5,000 -20.0% 7.52 US$37,600
2012-10-23 2012-10-22 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.72
US$38,600 		5,000 -20.0% 7.72 US$38,600
2012-10-05 2012-10-05 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.72
US$38,600 		5,000 -20.0% 7.72 US$38,600
2012-09-19 2012-09-18 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.57
US$37,850 		5,000 -20.0% 7.57 US$37,850
2012-09-06 2012-09-05 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.55
US$37,750 		5,000 -20.0% 7.55 US$37,750
2012-08-20 2012-08-20 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.67
US$38,350 		5,000 -20.0% 7.67 US$38,350
2012-08-15 2012-08-13 S Sale LUPINI LINDA

Senior VP, HR & Org. Dev.

Officer
77,007 -83.7%
7.58
US$583,929 		77,007 -83.7% 7.58 US$583,929
2012-08-10 2012-08-08 S Sale LUPINI LINDA

Senior VP, HR & Org. Dev.

Officer
22,993 -60.5%
7.85
US$180,495 		22,993 -60.5% 7.85 US$180,495
2012-08-08 2012-08-08 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.92
US$39,600 		5,000 -20.0% 7.92 US$39,600
2012-08-07 2012-08-03 S Sale Jagpal Sukhi

Interim CFO

Officer
67,000 -98.2%
8.19
US$548,730 		67,000 -98.2% 8.19 US$548,730
2012-07-25 2012-07-24 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
8.28
US$41,400 		5,000 -20.0% 8.28 US$41,400
2012-07-11 2012-07-09 S Sale CLARKE C BOYD

Former Director
20,000 -100.0%
7.62
US$152,460 		20,000 -100.0% 7.62 US$152,460
2012-07-11 2012-07-09 S Sale CLARKE C BOYD

Former Director
55,450 -100.0%
7.62
US$422,291 		55,450 -100.0% 7.62 US$422,291
2012-07-10 2012-07-09 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.53
US$37,650 		5,000 -20.0% 7.53 US$37,650
2012-06-22 2012-06-21 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.65
US$38,250 		5,000 -20.0% 7.65 US$38,250
2012-06-19 2012-06-15 PlS Planned sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,000 -20.0%
7.47
US$37,350 		5,000 -20.0% 7.47 US$37,350
2012-05-18 2012-05-16 B Purchase NB Public Equity K/S Large shareholder
50,000 +0.7%
6.67
US$333,340 		50,000 +0.7% 6.67 US$333,340
2012-05-16 2012-05-15 B Purchase CLARKE C BOYD Non-Executive Director
2,450 +3.4%
6.56
US$16,072 		2,450 +3.4% 6.56 US$16,072
2011-11-30 2011-11-29 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
20,000 -50.0%
6.73
US$134,522 		20,000 -50.0% 6.73 US$134,522
2011-11-30 2011-11-29 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
4,400 -9.9%
6.85
US$30,120 		4,400 -9.9% 6.85 US$30,120
2011-11-30 2011-11-28 S Sale Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
5,600 -21.9%
7.03
US$39,361 		5,600 -21.9% 7.03 US$39,361
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
1,300 +7.0%
6.78
US$8,813 		1,300 +7.0% 6.78 US$8,813
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
2,200 +13.3%
6.77
US$14,897 		2,200 +13.3% 6.77 US$14,897
2011-11-23 2011-11-23 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
1,500 +10.0%
6.76
US$10,143 		1,500 +10.0% 6.76 US$10,143
2011-11-23 2011-11-22 B Purchase Lussow Alexander R

Sr. VP, Bus. Dev. & Comm. Op.

Officer
400 +2.7%
6.96
US$2,783 		400 +2.7% 6.96 US$2,783
Explore more

More insider trading research around Novelion Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America